Mutabilis receives CARB-X grant for 'nightmare bacteria' treatment; AbSci and Xyphos shake hands on discovery deal
On a mission to subdue the rising global threat of antibiotic resistance, the CARB-X initiative has inked yet another grant …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
